Implementation and analysis of Pharmaceutical Care based on the communication between Community Pharmacists and Primary Care Physicians through a two-way online platform using the MEDAFAR communication language
DOI:
https://doi.org/10.60103/phc.v27.e872Keywords:
communication; drug-related problems; efficiency; pharmaceutical care; chronicity; community pharmacist; primary care physicianAbstract
Objective: To test a direct communication line between physicians and pharmacists to exchange information and manage drug-related problems and negative outcomes associated with medication identified by community pharmacists.
Methods: Cross-sectional opportunities study, with voluntary participation, performed in Aspe, Alicante. Every pharmacy owner from the community pharmacies and every primary care physician in the municipality participated.
Results: Drug-related problems appeared in 34,6% of the users, with 4,0 on average per user. The level of chronicity in the study population included 190 participants in chronicity level 0, 1.746 in level 1, 1.041 in level 2 and 592 in level 3. 14.233 derivations were performed, out of which 13.317 (93,6%) were out of Necessity, 684 (4,8%) involved Effectivity, 194 (1,4%) involved Information and 38 (0,3%) involved Security, with 93,0% being accepted by primary care physicians, 5,6% rejected, while 1,4% received no reply. The average yearly savings per user was quantified at 35,9€ and at 12,4€ per target user.
Conclusions: The use of a platform for direct communication between community pharmacists and primary care physicians using the MEDAFAR language enables the practice of a measurable Pharmaceutical Care, which favours the collaboration in the detection and solution of drug-related problems, with complex chronic patients being those who benefit the most. It improves efficacy, efficiency and security of healthcare, reducing the load on health centres and optimizing resources in the healthcare system.
Downloads
References
Nathan A, Sutters CA. A comparison of community pharmacists' and general practitioners' opinions on rational prescribing, formularies and other prescribing related issues. J R Soc Health. 1993;113(6):302-307. doi:10.1177/146642409311300606
Allemann SS, van Mil JW, Botermann L, Berger K, Griese N, Hersberger KE. Pharmaceutical care: the PCNE definition 2013. Int J Clin Pharm. 2014; 36(3):544-555. doi:10.1007/s11096-014-9933-x
Gilbert AL, Roughead EE, Beilby J, Mott K, Barratt JD. Collaborative medication management services: improving patient care. Med J Aust. 2002;177(4):189-192. doi:10.5694/j.1326-5377.2002.tb04730.x
Hughes CM, McCann S. Perceived interprofessional barriers between community pharmacists and general practitioners: a qualitative assessment. Br J Gen Pract. 2003; 53(493):600-606.
Porteous T, Bond C, Robertson R, Hannaford P, Reiter E. Electronic transfer of prescription-related information: comparing views of patients, general practitioners, and pharmacists. Br J Gen Pract. 2003; 53(488):204-209.
Florentinus SR, van Hulten R, Kramer M, et al. Which pharmacists contribute to high-level pharmacotherapy audit meetings with general practitioners? Ann Pharmacother. 2006; 40(9):1640-1646. doi:10.1345/aph.1H180
Storimans MJ, Klungel OH, Talsma H, Bouvy ML, de Blaey CJ. Collaborative services among community pharmacies for patients with diabetes. Ann Pharmacother. 2005; 39(10):1647-1653. doi:10.1345/aph.1G109
Bell JS, Whitehead P, Aslani P, McLachlan AJ, Chen TF. Drug-related problems in the community setting: pharmacists' findings and recommendations for people with mental illnesses. Clin Drug Investig. 2006; 26(7):415-425. doi:10.2165/00044011-200626070-00003
Denneboom W, Dautzenberg MG, Grol R, De Smet PA. Comparison of two methods for performing treatment reviews by pharmacists and general practitioners for home-dwelling elderly people. J Eval Clin Pract. 2008;14(3):446-452. doi:10.1111/j.1365-2753.2007.00900.x
Bryant LJ, Coster G, Gamble GD, McCormick RN. The General Practitioner-Pharmacist Collaboration (GPPC) study: a randomised controlled trial of clinical medication reviews in community pharmacy. Int J Pharm Pract. 2011;19(2):94-105. doi:10.1111/j.2042-7174.2010.00079.x
Ley 29/2006, de 26 de julio, de Garantías y Uso Racional de los Medicamentos y Productos Sanitarios. Boletín Oficial del Estado, número 178, de 27 de julio de 2016.
Real Decreto-ley 9/2011, de 19 de agosto, de medidas para la mejora de la calidad y cohesión del sistema nacional de salud, de contribución a la consolidación fiscal, y de elevación del importe máximo de los avales del Estado para 2011. Boletín Oficial del Estado, número 200, de 20 de agosto de 2011.
Organización Mundial de la Salud: Informe de Tokio sobre el papel del Farmacéutico en el sistema de atención de salud. Ars Pharm. 1995; 36: 285-92
Hepler CD, Strand LM. Opportunities and responsabilities in pharmaceutical care. Am J Hosp Pharm. 1990; 47: 533-43 Hepler CD, Strand LM. Oportunidades y responsabilidades en la Atención Farmacéutica. Pharm Care Esp 1999; 1: 35-47.
Cipolle RJ, Strand LM, Morley PC. Pharmaceutical Care Practice. New York: McGraw-Hill; 1998
Uribe G, Martínez de la Hidalga G. Médicos y farmacéuticos: éxitos y fracasos de colaboración profesional. SEMERGEN. 2002; 28(2):86-8.
Estrategia para el Abordaje de la Cronicidad en el Sistema Nacional de Salud. Informe de evaluación y líneas prioritarias de actuación. Julio 2019
Gallagher RM, Gallagher HC. Improving the working relationship between doctors and pharmacists: is inter-professional education the answer? Adv Health Sci Educ Theory Pract. 2012;17(2):247-257. doi:10.1007/s10459-010-9260-5
Jové AM, Fernández A, Hughes C, Guillén-Solà M, Rovira M, Rubio-Valera M. Perceptions of collaboration between general practitioners and community pharmacists: findings from a qualitative study based in Spain. J Interprof Care. 2014; 28(4):352-357. doi:10.3109/13561820.2014.898621
Alacreu M, Pardo J, Azorín M, Climent MT, Gasull V, Moreno L. Importance of Increasing Modifiable Risk Factors Knowledge on Alzheimer's Disease Among Community Pharmacists and General Practitioners in Spain. Front Pharmacol. 2019; 10:860. doi:10.3389/fphar.2019.00860
Amador-Fernández N, Benrimoj SI, García-Cárdenas V, et al. Identification of high-risk patients for referral through machine learning assisting the decision making to manage minor ailments in community pharmacies. Front Pharmacol. 2023; 14:1105434. doi:10.3389/fphar.2023.1105434
Cai S, Huang X, Van C, et al. General practitioners' attitudes towards and frequency of collaboration with pharmacists in China: a cross-sectional study. BMC Health Serv Res. 2023; 23(1):1174. doi:10.1186/s12913-023-10151-0
Chong JBK, Yap CYH, Tan SLL, Thong XR, Fang Y, Smith HE. General practitioners' perceptions of the roles of community pharmacists and their willingness to collaborate with pharmacists in primary care. J Pharm Policy Pract. 2023; 16(1):114. doi:10.1186/s40545-023-00613-5
Harris S, Mills E, Venables RH, Bradley F, White S. Developing consensus on the principles and key actions for collaborative working between general practices and community pharmacies: a modified eDelphi study. BMJ Open. 2023; 13(9):e074023. doi:10.1136/bmjopen-2023-074023
Pastor Sánchez R, Alberola Gómez-Escobar C, Álvarez de Toledo Saavedra F, Fernández de Cano Martín N, Solá Urruthy N. Clasificación de Derivaciones Fármaco-terapéuticas MEDAFAR. Madrid: IMC; 2008.
Hughes JS, Averill RF, Eisenhandler J, Goldfield NI, Muldoon J, Neff JM, Gay JC. Clinical Risk Groups (CRGs): a classification system for risk-adjusted capitation-based payment and health care management. Med Care. 2004; 42(1):81-90. doi: 10.1097/01.mlr.0000102367.93252.70. PMID: 14713742.
Norwegian Institute of Public Health [Internet]. NIPH; march 2024 [Acceso 3 septiembre 2024]. WHO Collaborating Centre for Drug Statistics Methodology. Disponible en: https://atcddd.fhi.no/atc_ddd_index/
Ley 20/2017de 28 de diciembre de la Generalitat de tasas. Diari Oficial de la Generalitat Valenciana, número 8202, publicado el 20 de diciembre de 2017.
Mate KS, Clark J, Salvon-Harman J. Harvard Business Review [Internet]. HBR; 12 de julio de 2024 [Acceso 20 septiembre 2024]. Para mejorar la atención sanitaria, hay que centrarse en mejorar los sistemas, no las personas. Disponible en: https://hbr.org/2024/07/to-improve-health-care-focus-on-fixing-systems-not-people
Mary L. Wagner, Caitlin McCarthy, M. Thomas Bateman, Daniel Simmons, Katherine M. Prioli, Pharmacists improve diabetes outcomes: a randomized controlled trial. Journal of the American Pharmacists Association. 2022; 62(3):775-782.e3. https://doi.org/10.1016/j.japh.2021.12.015.
Borenstein JE, Graber G, E Saltiel, Wallace J, Ryu S, J Archi, Deutsch S, Weingarten SR. Physician-pharmacist comanagement of hypertension: a randomized, comparative trial. Pharmacotherapy. 2003; 23 (2): 209-16.
Kwint HF, Bermingham L, Faber A, Gussekloo J, Bouvy ML. The relationship between the extent of collaboration of general practitioners and pharmacists and the implementation of recommendations arising from medication review: a systematic review. Drugs and Aging. 2013; 30(2): 91-102
Uribe G, Martínez de la Hidalga G. Médicos y farmacéuticos: éxitos y fracasos de colaboración profesional. Semergen. 2000; 28(2):86-8.
Ni XF, Yang CS, Bai YM, Hu ZX, Zhang LL. Drug-Related Problems of Patients in Primary Health Care Institutions: A Systematic Review. Front Pharmacol. 2021; 12:698907. doi: 10.3389/fphar.2021.698907. PMID: 34489695; PMCID: PMC8418140
Löffler C, Koudmani C, Böhmer F, Paschka SD, Höck J, Drewelow E, Stremme M, Stahlhacke B, Altiner A. Perceptions of interprofessional collaboration of general practitioners and community pharmacists - a qualitative study. BMC Health Serv Res. 2017;17(1):224. doi: 10.1186/s12913-017-2157-8.
Gilbert AL, Roughead EE, Beilby J, Mott K, Barratt JD. Collaborative medication management services: improving patient care. Med J Aust. 2002;177(4):189-192.
Peral Bolaños C, Santaolalla García I, Gómez Valbuena I, Vega Ruíz L, Iglesias Carabias C, Martín Valero R, et al. Intervención farmacéutica en la revisión del tratamiento en pacientes mayores polimedicados institucionalizados. Aten Primaria. 2024; 56(10):102959. Disponible en: http://dx.doi.org/10.1016/j.aprim.2024.102959
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Emilia Montagud Penadés, Javier Cremades Alcaraz, Raúl Moragues, Antonio Manuel Medina Toro, Hipólito Caro Moreno, Flor Alvarez de Toledo, Ana Dago
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
La revista Pharmaceutical Care España se publica bajo una licencia «Creative Commons, Reconocimiento, No Comercial y Compartir Igual 4.0 Internacional» (CC BY-NC-SA 4.0)», que permite a otros compartir el trabajo con un reconocimiento de la autoría del trabajo y la publicación inicial en esta revista (con excepción de los usos comerciales).
Los autores que publican en esta revista están de acuerdo con los siguientes términos:a) Los autores conservan los derechos de autor (derechos morales) y garantizan a la revista el derecho de ser el primer soporte documental publicado del trabajo.
b) Se permite y anima a los autores a difundir la versión del trabajo revisado por pares y aceptada para su publicación (por ejemplo, en repositorios institucionales o temáticos), recomendando hacerlo con la versión final del editor “pdf”, “html” o “xml”).
